(HIPO) Hippo Holdings - Ratings and Ratios
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US4335391037
HIPO EPS (Earnings per Share)
HIPO Revenue
HIPO: Home, Auto, Flood, Earthquake, Pet, Service Contracts
Hippo Holdings Inc. is a US-based insurance company that offers a range of property and casualty insurance products to individuals and businesses. Its business model is built around leveraging technology to provide a seamless customer experience, distributing insurance products and services through its online platforms and licensed agencies. The company operates through three main segments: Services, Insurance-as-a-Service, and Hippo Home Insurance Program, providing a diverse range of insurance products, including homeowners, personal, commercial, auto, flood, earthquake, and pet insurance.
What sets Hippo apart is its focus on using technology to innovate the insurance industry. By providing service contracts, home health check-ups, and home care advice, the company is attempting to create a more holistic insurance experience. This approach could potentially lead to increased customer loyalty and retention, driving long-term growth. With its headquarters in Palo Alto, California, Hippo is well-positioned to capitalize on the tech-savvy talent pool in the region.
Analyzing the available data, we can see that Hippos stock has been trending upwards, with its last price at $28.51, above its SMA20 and SMA50. The ATR indicates a moderate level of volatility. Given the companys negative P/E ratio and RoE of -15.74, its clear that Hippo is currently operating at a loss. However, if we consider the growth potential of the insurance industry and Hippos innovative approach, theres a possibility that the company could turn profitable in the future.
Using the available technical and fundamental data, a potential forecast for Hippos stock could be made. If we assume that the company continues to grow its revenue and eventually becomes profitable, its stock price could potentially reach $40-$50 in the next 12-18 months, representing a 40-75% increase from its current price. However, this is contingent on various factors, including the companys ability to execute its business plan, industry trends, and overall market conditions.
Additional Sources for HIPO Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
HIPO Stock Overview
Market Cap in USD | 737m |
Sector | Financial Services |
Industry | Insurance - Property & Casualty |
GiC Sub-Industry | Insurance Brokers |
IPO / Inception | 2021-08-03 |
HIPO Stock Ratings
Growth Rating | -47.9 |
Fundamental | 15.8 |
Dividend Rating | 0.0 |
Rel. Strength | 38.8 |
Analysts | 4 of 5 |
Fair Price Momentum | 21.77 USD |
Fair Price DCF | 14.79 USD |
HIPO Dividends
Currently no dividends paidHIPO Growth Ratios
Growth Correlation 3m | 28.2% |
Growth Correlation 12m | 61% |
Growth Correlation 5y | -55.8% |
CAGR 5y | -40.76% |
CAGR/Max DD 5y | -0.42 |
Sharpe Ratio 12m | -0.06 |
Alpha | 58.49 |
Beta | 1.343 |
Volatility | 73.19% |
Current Volume | 234.1k |
Average Volume 20d | 285.1k |
As of June 25, 2025, the stock is trading at USD 27.91 with a total of 234,053 shares traded.
Over the past week, the price has changed by -1.83%, over one month by +20.98%, over three months by +1.60% and over the past year by +74.77%.
Neither. Based on ValueRay´s Fundamental Analyses, Hippo Holdings is currently (June 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 15.81 and therefor a neutral outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of HIPO is around 21.77 USD . This means that HIPO is currently overvalued and has a potential downside of -22%.
Hippo Holdings has received a consensus analysts rating of 4.00. Therefor, it is recommend to buy HIPO.
- Strong Buy: 1
- Buy: 1
- Hold: 1
- Sell: 0
- Strong Sell: 0
According to our own proprietary Forecast Model, HIPO Hippo Holdings will be worth about 26 in June 2026. The stock is currently trading at 27.91. This means that the stock has a potential downside of -7.02%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | 36.5 | 30.8% |
Analysts Target Price | 30 | 7.5% |
ValueRay Target Price | 26 | -7% |